Diaceutics PLC (AIM:DXRX)

Market Cap	112.86M
Revenue (ttm)	32.16M
Net Income (ttm)	-1.70M
Shares Out	84.54M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	109.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,012
Average Volume	223,368
Open	133.85
Previous Close	133.50
Day's Range	132.00 - 135.00
52-Week Range	106.00 - 151.00
Beta	0.78
RSI	65.87
Earnings Date	Sep 17, 2025

About Oncternal Therapeutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 199
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DXRX

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.